- Report
- January 2025
- 200 Pages
Global
From €4096EUR$4,490USD£3,501GBP
- Report
- January 2025
- 200 Pages
Global
From €4096EUR$4,490USD£3,501GBP
- Report
- January 2025
- 200 Pages
Global
From €4096EUR$4,490USD£3,501GBP
- Report
- December 2024
- 175 Pages
Global
From €4561EUR$5,000USD£3,899GBP
- Report
- December 2024
- 175 Pages
Global
From €3649EUR$4,000USD£3,119GBP
- Report
- December 2024
- 175 Pages
Global
From €4561EUR$5,000USD£3,899GBP
- Report
- May 2024
- 271 Pages
Global
From €3193EUR$3,500USD£2,729GBP
€4561EUR$5,000USD£3,899GBP
- Report
- October 2024
- 183 Pages
Global
From €3234EUR$3,545USD£2,764GBP
€3593EUR$3,939USD£3,071GBP
- Report
- October 2024
- 180 Pages
Global
From €3234EUR$3,545USD£2,764GBP
€3593EUR$3,939USD£3,071GBP
- Report
- January 2025
- 142 Pages
Global
From €2736EUR$2,999USD£2,338GBP
- Report
- May 2024
- 133 Pages
Global
From €5929EUR$6,499USD£5,067GBP
- Report
- April 2025
- 147 Pages
Global
From €2736EUR$2,999USD£2,338GBP
- Report
- April 2025
- 135 Pages
Global
From €2736EUR$2,999USD£2,338GBP
- Report
- April 2025
- 147 Pages
Global
From €2736EUR$2,999USD£2,338GBP
- Report
- March 2025
- 142 Pages
Global
From €2736EUR$2,999USD£2,338GBP
- Report
- March 2025
- 149 Pages
Global
From €2736EUR$2,999USD£2,338GBP
- Report
- February 2025
- 137 Pages
Global
From €2736EUR$2,999USD£2,338GBP
- Report
- January 2025
- 132 Pages
Global
From €2736EUR$2,999USD£2,338GBP
- Report
- January 2025
- 124 Pages
Global
From €2736EUR$2,999USD£2,338GBP
- Report
- August 2024
- 149 Pages
Global
From €2736EUR$2,999USD£2,338GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more